
Methods: From June 2015 to March 2016, we performed a 9-month pilot (3 month baseline, 3 month phase-in, 3 month intervention) project in 3 nursing homes to study the impact of routine chlorhexidine (CHG) bathing/showering combined with use of nasal iodophor x 5 days on admission followed by every other week. Our primary outcome was body colonization with 4 MDROs, methicillin resistant S. aureus (MRSA), vancomycin resistant Enterococcus (VRE), extended spectrum beta-lactamase + (ESBL) and carbopenem resistant Enterobacteriaceae(CRE). We performed 6 sweeps of a random sample of 50 residents in both baseline and intervention periods, surveying skin (for MDROs) and nares (for MRSA). We also swabbed a standardized set of five commonly touched fomites in rooms of MDRO+ residents for MDRO environmental contamination.
Results: During the baseline period, 272/605 (45%) of residents were colonized with MDROs. After intervention implementation, there were significant (P<0.05) decreases in prevalence of MRSA (29% to 19%), VRE (12% to 4%), and ESBL (15 to 9%). CRE prevalence was rare (1%). Presence of any MDRO was reduced from 45% to 29% (P <0.001). In a multivariate model, clearance of MDROs was strongly associated with the intervention period (OR 0.41 [95% CI 0.36-0.55] when adjusting for clinical characteristics (Table). Residents tolerated the products well and staff acceptance was high. Contamination on >1 fomite in rooms of MDRO carriers was 88% before the intervention and 82% afterwards.
Conclusion: Routine use of CHG and nasal iodophor was pragmatically adopted into routine care within 3 months and associated with a marked reduction in MDRO prevalence among nursing home residents.
Factors Associated with MDRO Colonization During Study, OR [95% CI]
Intervention Period
0.41 [0.37-0.55]
Bed Bound Status
1.64 [1.23-2.20]
Incontinence
1.37 [1.09-1.71]
Foley present
1.91 [1.38-2.64]

L. Miller,
Sage Products:
Conducting studies in healthcare facilities that are receiving contributed product
,
Conducting studies in healthcare facilities that are receiving contributed product
3M:
Conducting studies in healthcare facilities that are receiving contributed product
,
Conducting studies in healthcare facilities that are receiving contributed product
Clorox:
Conducting studies in healthcare facilities that are receiving contributed product
,
Conducting studies in healthcare facilities that are receiving contributed product
R. Singh, Sage Products: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
3M: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Clorox: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
K. Kleinman, None
A. Gombosev, Sage Products: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Molnlycke: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
3M: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Clorox: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
T. Dutciuc, Sage Products: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
3M: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Clorox: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
K. Evans, None
T. Tjoa, None
L. Heim, Sage Products: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Clorox: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
3M: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
B. Launer, None
M. Bolaris, None
K. Ramsay, None
D. Kim, Sage Products: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
3M: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Clorox: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
M. Estevez, Sage Products: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
Clorox: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
3M: Conducting studies in healthcare facilities that are receiving contributed product , Conducting studies in healthcare facilities that are receiving contributed product
E. Peterson, None
S. S. Huang, Sage Products: Conducting studies in which participating healthcare facilities are receiving contributed product (no contribution in submitted abstract) , Participating healthcare facilities in my studies received contributed product
Molnlycke: Conducting studies in which participating healthcare facilities are receiving contributed product (no contribution in submitted abstract) , Participating healthcare facilities in my studies received contributed product
3M: Conducting studies in which participating healthcare facilities are receiving contributed product (no contribution in submitted abstract) , Participating healthcare facilities in my studies received contributed product
Clorox: Conducting studies in which participating healthcare facilities are receiving contributed product (no contribution in submitted abstract) , Participating healthcare facilities in my studies received contributed product